CASP3 and ischemia: Subacute administration of zinc showed a cytoprotector effect leading to a decrease in the lipoperoxidation and immunoreactivity against cleaved caspase-3 by preventing an accumulation of zinc and increase of NO production in the late phase of a hypoxia-ischemia process.